These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 19160530)

  • 1. Elevated angiogenin levels in chronic heart failure.
    Patel JV; Sosin M; Gunarathne A; Hussain I; Davis RC; Hughes EA; Lip GY
    Ann Med; 2008; 40(6):474-9. PubMed ID: 19160530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stepwise increase of angiopoietin-2 serum levels is related to haemodynamic and functional impairment in stable chronic heart failure.
    Eleuteri E; Di Stefano A; Tarro Genta F; Vicari C; Gnemmi I; Colombo M; Mezzani A; Giannuzzi P
    Eur J Cardiovasc Prev Rehabil; 2011 Aug; 18(4):607-14. PubMed ID: 21450636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma endothelin-1 levels and clinical correlates in patients with chronic heart failure.
    Kinugawa T; Kato M; Ogino K; Osaki S; Igawa O; Hisatome I; Shigemasa C
    J Card Fail; 2003 Aug; 9(4):318-24. PubMed ID: 13680553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of copeptin, B-type natriuretic peptide, and amino-terminal pro-B-type natriuretic peptide in patients with chronic heart failure: prediction of death at different stages of the disease.
    Neuhold S; Huelsmann M; Strunk G; Stoiser B; Struck J; Morgenthaler NG; Bergmann A; Moertl D; Berger R; Pacher R
    J Am Coll Cardiol; 2008 Jul; 52(4):266-72. PubMed ID: 18634981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlates of B-type natriuretic peptide and 6-min walk in heart failure patients.
    Hogenhuis J; Jaarsma T; Voors AA; Hillege HL; Lesman I; van Veldhuisen DJ
    Int J Cardiol; 2006 Mar; 108(1):63-7. PubMed ID: 16516699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Different characteristics of chronic heart failure (CHF) in elderly diabetics and non-diabetics.
    Romeo R; Scalisi C; Tafuri L; Romeo A; Maugeri D; Sorace R
    Arch Gerontol Geriatr; 2010; 50(1):101-4. PubMed ID: 19371958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma brain natriuretic peptide predicts short-term clinical outcome in heart failure patients with restrictive filling pattern.
    Feola M; Aspromonte N; Milani L; Bobbio M; Bardellotto S; Barro S; Giovinazzo P; Noventa F; Valle R
    J Card Fail; 2008 Jun; 14(5):420-5. PubMed ID: 18514935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal rhythmic oscillations of atrial natriuretic peptide and brain natriuretic peptide in heart failure.
    Bentzen H; Pedersen RS; Pedersen HB; Nyvad O; Pedersen EB
    Clin Sci (Lond); 2003 Mar; 104(3):303-12. PubMed ID: 12605591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial activation, dysfunction, and damage in congestive heart failure and the relation to brain natriuretic peptide and outcomes.
    Chong AY; Freestone B; Patel J; Lim HS; Hughes E; Blann AD; Lip GY
    Am J Cardiol; 2006 Mar; 97(5):671-5. PubMed ID: 16490435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical correlates of elevated plasma natriuretic peptides and Big endothelin-1 in a population of ambulatory patients with heart failure. A substudy of the Italian Network on Congestive Heart Failure (IN-CHF) registry. IN-CHF Investigators.
    Masson S; Gorini M; Salio M; Lucci D; Latini R; Maggioni AP
    Ital Heart J; 2000 Apr; 1(4):282-8. PubMed ID: 10824729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A direct comparison of the natriuretic peptides and their relationship to survival in chronic heart failure of a presumed non-ischaemic origin.
    Stanton E; Hansen M; Wijeysundera HC; Kupchak P; Hall C; Rouleau JL;
    Eur J Heart Fail; 2005 Jun; 7(4):557-65. PubMed ID: 15921795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Right heart overload contributes to cardiac natriuretic hormone elevation in patients with heart failure.
    Passino C; Maria Sironi A; Favilli B; Poletti R; Prontera C; Ripoli A; Lombardi M; Emdin M
    Int J Cardiol; 2005 Sep; 104(1):39-45. PubMed ID: 16137508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating erythropoietin levels and prognosis in patients with congestive heart failure: comparison with neurohormonal and inflammatory markers.
    George J; Patal S; Wexler D; Abashidze A; Shmilovich H; Barak T; Sheps D; Keren G
    Arch Intern Med; 2005 Jun; 165(11):1304-9. PubMed ID: 15956012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma von Willebrand factor and soluble E-selectin levels in stable outpatients with systolic heart failure: the Frederiksberg heart failure study.
    Chong AY; Freestone B; Lim HS; Kistorp C; Gustafsson F; Hildebrandt P; Lip GY
    Int J Cardiol; 2007 Jun; 119(1):80-2. PubMed ID: 17027106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low pulse pressure is independently related to elevated natriuretic peptides and increased mortality in advanced chronic heart failure.
    Voors AA; Petrie CJ; Petrie MC; Charlesworth A; Hillege HL; Zijlstra F; McMurray JJ; van Veldhuisen DJ
    Eur Heart J; 2005 Sep; 26(17):1759-64. PubMed ID: 15833758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart-type fatty acid-binding protein is more sensitive than troponin T to detect the ongoing myocardial damage in chronic heart failure patients.
    Niizeki T; Takeishi Y; Arimoto T; Takabatake N; Nozaki N; Hirono O; Watanabe T; Nitobe J; Harada M; Suzuki S; Koyama Y; Kitahara T; Sasaki T; Kubota I
    J Card Fail; 2007 Mar; 13(2):120-7. PubMed ID: 17395052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure.
    Selvais PL; Robert A; Ahn S; van Linden F; Ketelslegers JM; Pouleur H; Rousseau MF
    J Card Fail; 2000 Sep; 6(3):201-7. PubMed ID: 10997745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Brain natriuretic peptide (BNP) in coronary insufficiency: relationship with left ventricular filling and exercise tolerance].
    Logeart D; Gambert A; Beyne P; Guiti C; Geyer C; Bourgoin P; Alonso C; Ennezat PV; Gourgon R; Cohen-Solal A
    Ann Cardiol Angeiol (Paris); 1999 Sep; 48(7):523-8. PubMed ID: 12555377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In patients with severe systolic dysfunction, only brain natriuretic peptide is related to diastolic restrictive pattern.
    Catuzzo B; Ciancamerla F; Bobbio M; Longo M; Trevi GP
    J Card Fail; 2003 Aug; 9(4):303-10. PubMed ID: 13680551
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.